LYZ and infection: This observation suggests that inhibiting lytic transglycosylase activity, for instance through the antibiotic bulgecin A [71], could effectively combat infections with gram-negative bacteria by reducing envelope integrity and consequently enhancing their sensitivity to killing by lysozyme and potentially other innate immune components.